BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 07:28 pm

Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve ....

Sharma East India Hospitals & Medical Research Ltd · 524548

✦ AI SummaryResults

Sharma East India Hospitals & Medical Research Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve IND-AS compliant standalone un-audited financial results for the quarter ended on 30th June 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sharma East India Hospitals & Medical Research Ltd - 524548 - Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements), Regulations 2015.

Attachments (1)

📄

53516337-82c0-48b0-9f4c-ddd43cc19357.pdf

pdf

Download →
View document text
I I . S~A~ EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD. Regd. Office: Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur-302015 (Raj.) Phone: 0141-2742557, 2742266 CIN: L85110RJ1989PLC005206 E-Mail: sharmaeastindia@gmail.com Website: www.jaipurhospital.co. in August 4, 2026 The Manager, Corporate Relationship Department, BSE Ltd. 25th Floor P.J. Towers, Dalal Street, Fort, MUMBAI-400 001 Subject.: Intimation under re&ulation 29 of SEBI (Listin& Obli&ations and Disclosure Reguirements), Re&ulations 2015 for holdin& Board Meetin& for approval of on-audited financial results for the Quarter ended 30th June 2026 and other matters Ref: Scrip Code: -524548 Dear Sir, This is to inform you that, the meeting of the Board of Directors of Sharma East India Hospitals & Medical Research Limited is scheduled to be held on Wednesday the August 12, 2026, at the registered office of the Company, to transact inter alia, the following business: 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to regulation 33 of the SEBI (Listing Obligations anq Disclosure Requirements), Regulations 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. Further, as communicated earlier, in accordanj::e with Company's Code of Conduct for Prevention of Insider Trading in securities of the Compaqy and pursuant to the SEBI (Prohibition of Insirler Trading) Regulations 2015, the Trading Window for dealing in securities of the Company is already closed from Wednesday 1st July 202~ until Forty-Eight (48) hours after declaration of un-audited financial results for the quarter ended on 30th June 2026, on stock exchange. Kindly take it on record and acknowledge the same. Thanki11g You, Yours tru'ly, For ~t14RMA . T JNDIA HOSPITALS & MEDICAL RESEARCH LIMITED "t.iawana Sflarma ((;o~p~ny Secretary Ap<A f;~~pliance Officer) M. No, A61665 Place: Jaipur